Validation of the OAC3-PAD PAD Bleeding Risk Score in Patients with Peripheral Arterial Disease after Endovascular Treatment

被引：1
|
作者：
Boc, Vinko [1 ,2 ]
Pelicon, Kevin [1 ]
Petek, Klemen [1 ]
Boc, Anja [1 ,3 ]
Kejzarar, Natasa [4 ]
Blinc, Ales [1 ,2 ]
机构：
[1] Univ Med Ctr Ljubljana, Dept Vasc Dis, Zaloska 7, Ljubljana 1525, Slovenia
[2] Univ Ljubljana, Fac Med, Dept Internal Med, Ljubljana, Slovenia
[3] Univ Ljubljana, Inst Anat, Fac Med, Ljubljana, Slovenia
[4] Univ Ljubljana, Inst Biostat & Med Informat, Fac Med, Ljubljana, Slovenia
来源：
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY | 2024年 / 68卷 / 02期
关键词：
Endovascular procedure; Haemorrhage; Peripheral arterial disease; Risk; assessment; Validation study;
D O I：
10.1016/j.ejvs.2024.03.036
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：266 / 267
页数：2
相关论文
共 50 条
  • [31] Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone
    Berkowitz, Scott D.
    Bauersachs, Rupert M.
    Szarek, Michael
    Nehler, Mark R.
    Debus, E. Sebastian
    Patel, Manesh R.
    Anand, Sonia S.
    Capell, Warren H.
    Hess, Connie N.
    Hsia, Judy
    Leeper, Nicholas J.
    Brasil, David
    Matyas, Lajos
    Diaz, Rafael
    Brodmann, Marianne
    Muehlhofer, Eva
    Haskell, Lloyd P.
    Bonaca, Marc P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022, 20 (05) : 1193 - 1205
  • [32] The relation of anatomical distribution of symptomatic peripheral arterial disease (PAD) with HbA1c level in patients with type 2 diabetes mellitus
    Shatnawi, Nawaf J.
    Al-Zoubi, Nabil A.
    Hawamdeh, Hassan M.
    Khader, Yousef S.
    Heis, Mowafeq
    Al Omari, Mamoon
    Bataineh, Bassem
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2021, 12
  • [33] Association of Serum Uric Acid Levels with Leg Ischemia in Patients with Peripheral Arterial Disease after Treatment
    Sotoda, Yoko
    Hirooka, Shigeki
    Orita, Hiroyuki
    Wakabayashi, Ichiro
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2017, 24 (07) : 725 - 734
  • [34] Intravascular brachytherapy: a systematic review of its role in reducing restenosis after endovascular treatment in peripheral arterial disease
    Hansrani, M
    Overbeck, K
    Smout, J
    Stansby, G
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2002, 24 (05) : 377 - 382
  • [35] Incidence and risk factors of vascular complications following endovascular treatment of peripheral arterial disease via the popliteal artery
    Yanagita Y.
    Noda K.
    Cardiovascular Intervention and Therapeutics, 2011, 26 (3) : 209 - 214
  • [36] Cost-effectiveness of risk assessment and tailored treatment for peripheral arterial disease patients
    Vaidya, Anil
    Joore, Manuela A.
    ten Cate-Hoek, Arina J.
    ten Cate, Hugo
    Severens, Johan L.
    BIOMARKERS IN MEDICINE, 2014, 8 (08) : 989 - 999
  • [37] The addition of evolocumab to maximal tolerated statin therapy improves walking performance in patients with peripheral arterial disease and intermittent claudication (Evol-PAD study)
    Clavijo, Leonardo C.
    Caro, Jorge
    Choi, Jongkyu
    Caro, Jorge A.
    Tun, Han
    Rowe, Vincent
    Kumar, S. Ram
    Shavelle, David M.
    Matthews, Ray V.
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2023, 55 : 52 - 56
  • [38] Clinical outcome after bleeding events following coronary stenting in patients with and without comorbid peripheral arterial disease
    Pinxterhuis, Tineke H.
    Ploumen, Eline H.
    Kok, Marlies M.
    Schotborgh, Carl E.
    Anthonio, Rutger L.
    Roguin, Ariel
    Danse, Peter W.
    Benit, Edouard
    Aminian, Adel
    Hartmann, Marc
    Linssen, Gerard C. M.
    Geelkerken, Robert H.
    Doggen, Carine J. M.
    von Birgelen, Clemens
    CARDIOVASCULAR INTERVENTION AND THERAPEUTICS, 2025, 40 (02) : 287 - 295
  • [39] Comparison of the Framingham Risk Score, UKPDS Risk Engine, and SCORE for Predicting Carotid Atherosclerosis and Peripheral Arterial Disease in Korean Type 2 Diabetic Patients
    Ahn, Hye-Ran
    Shin, Min-Ho
    Yun, Woo-Jun
    Kim, Hye-Yeon
    Lee, Young-Hoon
    Kweon, Sun-Seog
    Rhee, Jung-Ae
    Choi, Jin-Su
    Choi, Seong-Woo
    KOREAN JOURNAL OF FAMILY MEDICINE, 2011, 32 (03): : 189 - 196
  • [40] Treatment with cilostazol improves clinical outcome after endovascular therapy in hemodialysis patients with peripheral artery disease
    Ishii, Hideki
    Aoyama, Toru
    Takahashi, Hiroshi
    Kumada, Yoshitaka
    Kamoi, Daisuke
    Sakakibara, Takashi
    Umemoto, Norio
    Suzuki, Susumu
    Tanaka, Akihito
    Ito, Yasuhiko
    Murohara, Toyoaki
    JOURNAL OF CARDIOLOGY, 2016, 67 (1-2) : 199 - 204
12345